Regeneron Pharmaceuticals, Inc. / Congress transactions
Members of the U.S. Congress are required to report their stock transactions in U.S. companies within 45 days. The requirement extends to their spouses and dependent children.
| Name | Transaction date | Value | |
|---|---|---|---|
| Robert Bresnahan | Purchase | $1.00K–$15.00K | |
| Byron Donalds | Sale | $1.00K–$15.00K | |
| Julie Johnson | Sale | $1.00K–$15.00K | |
| Robert Bresnahan | Sale | $1.00K–$15.00K | |
| Jefferson Shreve | Sale | $15.00K–$50.00K | |
| Robert Bresnahan | Sale | $1.00K–$15.00K | |
| Julie Johnson | Sale | $1.00K–$15.00K | |
| Julie Johnson | Purchase | $1.00K–$15.00K | |
| Josh Gottheimer | Sale | $1.00K–$15.00K | |
| Jonathan Jackson | Sale | $16.00K–$65.00K | |
| Josh Gottheimer | Sale | $1.00K–$15.00K | |
| Greg Landsman | Sale | $1.00K–$15.00K | |
| Josh Gottheimer | Sale | $1.00K–$15.00K | |
| Josh Gottheimer | Sale | $1.00K–$15.00K | |
| Greg Landsman | Purchase | $1.00K–$15.00K |